Kosin Medical Journal

Case report

Perioperative cutaneous complications in an elderly patient due to inappropriate use of a forced-air warming device and underbody blanket: a case report: Myounghun Kim, Soo Jee Lee, Beomseok Choi, Geunho Lee, Seunghee Ki; Kosin Med J. 2023;38(4):288-292. Published online December 6, 2023; DOI: https://doi.org/10.7180/kmj.23.136

5,169 View
43 Download
1 Citations

Forced-air warming is commonly utilized to prevent perioperative hypothermia. Underbody warming blankets are often employed to secure a larger area for patient warming. While forced-air warming systems are generally regarded as safe, improper usage poses a risk of cutaneous complications. Additionally, the influence of underbody blankets on cutaneous complications remains uncertain. We present a case of cutaneous complications resulting from the improper utilization of a forced-air warming device and an underbody blanket. A 79-year-old man presented to the hospital for robotic proctectomy under general anesthesia. The surgery lasted for 7 hours, and the forced-air warming device with underbody blanket operated continuously for 5 hours intraoperatively. The surgery was completed without any incidents. However, first-degree burns on the patient’s back, along with superficial decubitus ulcers on his right scapula, were observed after surgery. To prevent cutaneous complications, clinicians must adhere to the manufacturer's guidelines when utilizing a forced-air warming system. Compared to overbody blankets, underbody blankets have limitations in monitoring cutaneous responses. Ensuring patient safety requires selecting an appropriate blanket for scheduled operations.

Citations

Citations to this article as recorded by

Comparison between upper body and full underbody forced-air warming blanket in pediatric patients undergoing cardiovascular interventions under general anesthesia: a randomized controlled trial
Jung-Bin Park, Tae-Won Kim, Sang-Hwan Ji, Young-Eun Jang, Ji-Hyun Lee, Jin-Tae Kim, Hee-Soo Kim, Eun-Hee Kim
BMC Anesthesiology.2025;[Epub] CrossRef

Review article

An Overview of the Clinical Efficacy and Safety of Tissue Selective Estrogen Complex: From the Selective Estrogens, Menopause, and Response to Therapy (SMART) Trials: Sung Wook Chun; Kosin Med J. 2017;32(1):5-16. Published online June 30, 2017; DOI: https://doi.org/10.7180/kmj.2017.32.1.5

2,835 View
13 Download
1 Citations

Abstract PDF PubReader ePub

Hormone therapy (HT) is the most effective treatment for menopausal symptoms, and reduces both spinal and non-spinal postmenopausal osteoporotic fractures. However, a Women's Health Initiative (WHI) trial revealed that progestin-containing HT is associated with higher incidences of breast cancer and coronary heart disease than those associated with placebo. Tissue selective estrogen complex (TSEC) is a novel progestin-free HT option composed of conjugated estrogens (CE) and a selective estrogen receptor modulator. CE at a dose of 0.45 mg combined with 20 mg of bazedoxifene was the first TSEC medication approved in the United States and Korea for women with moderate to severe menopause-related vasomotor symptoms (VMS) and for preventing postmenopausal osteoporosis. This review summarizes the clinical efficacy, safety, and tolerability of TSEC as obtained from the five SMART clinical trials.

Citations

Citations to this article as recorded by

Effects of combined estrogen and bazedoxifene (CEB) on depressive symptoms in perimenopause
Erin Bondy, Julianna Prim, David Rubinow, Lauren Schiff, Gabriel S. Dichter, Crystal E. Schiller
Journal of Affective Disorders.2025; 390: 119853. CrossRef

Original article

The Early Learning Curve for Laparoscopic Colorectal Surgery: Seung Hyun Lee, Byung Kwon Ahn, Sung Uhn Baek; Kosin Med J. 2007;22(1):129-133. Published online June 30, 2007

647 View
0 Download

PDF

First
Prev
Page of 1
Next
Last

Search